Serum Ghrelin in Polycystic Ovary Syndrome

March 13, 2014 updated by: amr hesham el etreby

Ghrelin in Polycystic Ovary Syndrome

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

Study Overview

Status

Unknown

Conditions

Detailed Description

two groups one healthy and other with pco measure ghrelin level in both of them to find relation between pco and ghrelin

Study Type

Observational

Enrollment (Anticipated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Maternity Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • amr h eletreby, mbbch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Forty two patients with polycystic ovarian syndrome and forty two healthy subjects will be recruited from the outpatient clinic Ain Shams University Maternity Hospital.

Description

Inclusion Criteria:pco women

  • At least 12 months of infertility.
  • Patients with polycystic ovarian syndrome according to Rotterdam criteria:

Exclusion Criteria:

  • Patients with hyperprolactinemia
  • Patients with Cushing's syndrome
  • Patients with Congenital or non-classical adrenal hyperplasia
  • Patients with hormone secreting tumors.
  • Patients with hormonal treatment in the last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
study
patients with polycystic ovary syndrome
control
healthy patients serves as control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
relationships between circulating ghrelin and the clinical and biochemical manifestations of PCOS
Time Frame: after 6 monthes
Analysis of levels of ghrelin in study group
after 6 monthes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

amr hesham el etreby

Investigators

  • Principal Investigator: amr eletrby, MBBCH, ain shams universty maternity hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Anticipated)

October 1, 2014

Study Completion (Anticipated)

December 1, 2014

Study Registration Dates

First Submitted

March 12, 2014

First Submitted That Met QC Criteria

March 13, 2014

First Posted (Estimate)

March 14, 2014

Study Record Updates

Last Update Posted (Estimate)

March 14, 2014

Last Update Submitted That Met QC Criteria

March 13, 2014

Last Verified

March 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Ghrelin

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polycystic Ovary

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe